Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Sci-Tech News Today.
Press releases published on May 7, 2025
Nametag Joins IDPro to Support the Future of Digital Identity
GlobeNewswire
·
May 7, 2025
SEATTLE, May 07, 2025 (GLOBE NEWSWIRE) -- Nametag, the identity verification company on a mission to protect people’s accounts and foster trust in online interactions, today announced its sponsorship of IDPro®, a vibrant community of Identity …
Mineralys Therapeutics to Participate in the Bank of America Securities Health Care Conference
GlobeNewswire
·
May 7, 2025
RADNOR, Pa., May 07, 2025 (GLOBE NEWSWIRE) -- Mineralys Therapeutics, Inc. (Nasdaq: MLYS), a clinical-stage biopharmaceutical company focused on developing medicines to target hypertension, chronic kidney disease (CKD), obstructive sleep apnea (OSA) and …
CorVista Health Announces European Respiratory Journal Publication Detailing Validation of its Non-Invasive Test for Pulmonary Hypertension
GlobeNewswire
·
May 7, 2025
Data demonstrates CorVista’s proprietary machine-learned algorithm detects elevated mean pulmonary artery pressure (mPAP) with strong sensitivity and specificity across diverse patient populations BETHESDA, Md., May 07, 2025 (GLOBE NEWSWIRE) -- CorVista …
Verrica Pharmaceuticals to Report First Quarter 2025 Financial Results and Provide a Corporate Update on May 13, 2025
GlobeNewswire
·
May 7, 2025
WEST CHESTER, Pa., May 07, 2025 (GLOBE NEWSWIRE) -- Verrica Pharmaceuticals Inc. (“Verrica” or “the Company”) (Nasdaq: VRCA), a dermatology therapeutics company developing medications for skin diseases requiring medical interventions, today announced that …
KVH Launches CommBox Edge Secure Suite for Advanced Cybersecurity Threat Detection & Response
GlobeNewswire
·
May 7, 2025
MIDDLETOWN, R.I., May 07, 2025 (GLOBE NEWSWIRE) -- Today, KVH Industries, Inc. (Nasdaq: KVHI) unveiled the newest expansion to its CommBox™ Edge Communications Gateway–the Secure Suite threat detection and response service. Focused on detecting, preventing …
Actuate Therapeutics to Host KOL Event on Topline Phase 2 Data of Elraglusib in Metastatic Pancreatic Ductal Adenocarcinoma During ASCO Annual Meeting
GlobeNewswire
·
May 7, 2025
Fireside discussion to explore clinical impact of the topline Phase 2 data in first-line metastatic pancreatic ductal adenocarcinoma (mPDAC) to be presented at ASCO In-person event and virtual webcast to be held on Saturday, May 31, 2025, at 6:30 pm CDT …
Clene Reports First Quarter 2025 Financial Results and Recent Operating Highlights
GlobeNewswire
·
May 7, 2025
Clene preparing for upcoming meeting in the second quarter with the U.S. Food and Drug Administration (FDA) to reach agreement on its statistical analysis plan (SAP) regarding analysis of neurofilament light chain (NfL) biomarker data Clene collecting NfL …
Liberation Labs Announces Manufacturing Partnership with Vivici
GlobeNewswire
·
May 7, 2025
RICHMOND, Ind., May 07, 2025 (GLOBE NEWSWIRE) -- Liberation Labs today announced a manufacturing partnership with Dutch ingredients startup Vivici. Liberation Labs will produce Vivici’s flagship ingredient, Vivitein™ BLG, at its Richmond, Indiana facility …
Tectonic Therapeutic To Present on May 15th, 2025 at the Bank of America Securities Health Care Conference
GlobeNewswire
·
May 7, 2025
WATERTOWN, Mass., May 07, 2025 (GLOBE NEWSWIRE) -- Tectonic Therapeutic, Inc. (NASDAQ: TECX) (“Tectonic”), a clinical stage biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of …
Otto Aviation CEO Paul Touw to Serve as Keynote Speaker at the 4th Annual Sustainable Skies World Summit
GlobeNewswire
·
May 7, 2025
FORTH WORTH, Texas, May 07, 2025 (GLOBE NEWSWIRE) -- Otto Aviation, a pioneering force in sustainable aviation, today announced that its CEO Paul Touw will serve as a keynote speaker at the 4th annual Sustainable Skies World Summit 2025, organized and …
CervoMed to Participate in H.C. Wainwright 3rd Annual BioConnect Investor Conference
GlobeNewswire
·
May 7, 2025
BOSTON, May 07, 2025 (GLOBE NEWSWIRE) -- CervoMed Inc. (NASDAQ: CRVO), a clinical stage company focused on developing treatments for age-related neurologic disorders (CervoMed or the Company), today announced that Company management will participate in a …
Twin Disc Announces Third Quarter Results
GlobeNewswire
·
May 7, 2025
MILWAUKEE, May 07, 2025 (GLOBE NEWSWIRE) -- Twin Disc, Inc. (NASDAQ: TWIN) today reported results for the third quarter ended March 28, 2025. Fiscal Third Quarter 2025 Highlights Sales increased 9.5% year-over-year to $81.2 million Net loss attributable to …
Sterling Solutions Offers TerraCross, Industry’s Quick-Deployment, Engineered, Cross-Laminated Timber Temporary Bridge
GlobeNewswire
·
May 7, 2025
PHOENIX, Ill., May 07, 2025 (GLOBE NEWSWIRE) -- Sterling Site Access Solutions, a leading construction site access provider and the largest producer of Cross Laminated Timber (CLT) in North America introduces TerraCross, a quick-to-deploy, temporary bridge …
GlobalTech and Talina AI Initiate Collaboration to Innovate AI-Driven Global Talent Acquisition
GlobeNewswire
·
May 7, 2025
DUBAI, United Arab Emirates, May 07, 2025 (GLOBE NEWSWIRE) -- GlobalTech Corporation (GLTK: US)(“GlobalTech” or the “Company”) announces that it has entered into a Partnership Agreement with Talina AI Consultancies L.L.C. (“Talina”) to help usher in a new …
New Preclinical Data for Assembly Biosciences’ Oral Hepatitis D Virus Entry Inhibitor ABI-6250 and Next-Generation Hepatitis B Virus Capsid Assembly Modulator ABI-4334 Presented at the EASL Congress 2025
GlobeNewswire
·
May 7, 2025
– Late-breaker poster highlights preclinical profile of ABI-6250, currently in Phase 1a with data anticipated in Q3 2025 – – Second poster describes in vitro studies of effects on viral infection markers by ABI-4334, currently in Phase 1b with data …
PDS Biotech Announces Conference Call and Webcast for First Quarter 2025 Financial Results
GlobeNewswire
·
May 7, 2025
PRINCETON, N.J., May 07, 2025 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB) (“PDS Biotech” or the “Company”), a late-stage immunotherapy company focused on transforming how the immune system targets and kills cancers, today announced …
Disc Medicine Reports First Quarter 2025 Financial Results and Provides Business Update
GlobeNewswire
·
May 7, 2025
Company remains on track to submit NDA for bitopertin in erythropoietic protoporphyria (EPP) in H2 2025 Initiated APOLLO, a confirmatory clinical trial of bitopertin in adults and adolescents with EPP Plan to initiate Phase 2 study of DISC-3405 in …
ARS Pharmaceuticals’ neffy® (epinephrine nasal spray) 1 mg is Now Available in the United States for Type I Allergic Reactions, including Anaphylaxis, in Pediatric Patients Weighing 15 to < 30 Kilograms
GlobeNewswire
·
May 7, 2025
The availability of neffy 1 mg extends protection to younger, school-aged children—who make up nearly 23% of people needing epinephrine Visit neffy.com for savings and support programs and pay as little as $25 (if eligible) in preparation for summer travel …
Erasca to Present at the Bank of America Securities Health Care Conference
GlobeNewswire
·
May 7, 2025
SAN DIEGO, May 07, 2025 (GLOBE NEWSWIRE) -- Erasca, Inc. (Nasdaq: ERAS), a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers, today …
BioVie to Present Rationale and Design of Phase 2 SUNRISE-PD Clinical Trial at the 30th World Congress on Parkinson’s Disease and Related Disorders (IAPRD 2025)
GlobeNewswire
·
May 7, 2025
CARSON CITY, Nev., May 07, 2025 (GLOBE NEWSWIRE) -- BioVie Inc., (NASDAQ: BIVI) (“BioVie” or the “Company”) a clinical-stage company developing innovative drug therapies for the treatment of neurological and neurodegenerative disorders and advanced liver …